Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
According to recent data from the Centers for Disease Control and Prevention (CDC), the percentage of individuals reporting Long COVID symptoms has decreased from 19% in June 2022 to 11% in January 2023 among those who have had COVID-19. While this decline is notable, 15% of all US adults have reported experiencing Long COVID symptoms at some point, with 6% currently affected. Long COVID continues to pose challenges, including limitations in daily activities for 79% of those affected and potential long-term disabilities. Efforts to address Long COVID include research initiatives and public health actions, but its full impact and the reasons behind the decline in reported cases remain subjects of ongoing study and concern.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Other
The article discusses the challenges and frustrations surrounding Long COVID research in the United States. Despite substantial investments and numerous research efforts, progress in understanding and treating Long COVID has been slow and disappointing. Experts and patient advocates have criticized the research community for its focus on disease development rather than direct patient care, duplication of studies, and a lack of clinical trials. The authors propose a new hypothesis that Long COVID may be a form of post-infectious syndrome or chronic fatigue syndrome, suggesting that traditional biomedical research approaches may not yield meaningful results. Instead, they advocate for a shift towards health services research and measures that directly impact patients’ welfare, including prevention, improved prognosis, access to empathetic care, and quality of life issues. They emphasize the need for collaboration between researchers, patients, and advocacy groups to reset the research agenda effectively.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The study conducted by the Centers for Disease Control and Prevention (CDC) and Federal Emergency Management Agency (FEMA) assessed high-throughput COVID-19 vaccination sites in the United States, including Puerto Rico, to identify promising practices for their implementation. Through site observations and staff interviews, they conducted 134 assessments in multiple states, highlighting practices related to health equity, partnerships, site design, visual communication, quick response codes, and risk management. These findings can aid in the planning and execution of future vaccination operations for COVID-19, influenza, and other vaccine-preventable diseases, offering valuable insights to vaccination planners and providers for strengthening their site plans and implementation strategies.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
Using a grant from the National Science Foundation, Predictive Intelligence for Pandemic Prevention (PIPP) developed tools and systems to respond effectively to infectious disease pandemics. Recommendations from this work include avoiding reinvention of the wheel by centralizing and standardizing approaches to pandemic response planning, collaboration and information sharing among public health stakeholders, investing in high-performance computing and data management systems for public health, creating a national center for pandemic response, developing playbooks for fast-moving threats, and identifying sustainable and scalable solutions.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Summary Report/Recommendations
This commentary discusses the importance of inclusive health systems strengthening in promoting equity during health emergencies, using the example of disability inclusion in the COVID-19 pandemic. It highlights the increased risks faced by persons with disabilities during the pandemic and the barriers they encounter in accessing healthcare. It emphasizes the need for accessible and comprehensive health emergency preparedness and response plans that consider the needs of persons with disabilities. It also explores strategies for disability inclusion in COVID-19 responses, such as producing accessible public health information and involving organizations of persons with disabilities in decision-making processes. Opportunities to strengthen inclusion and equity in COVID-19 responses include equitable access to telehealth and inclusive decision-making processes.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
Mask mandates in states beginning in 2020 had a significant impact on COVID-19-related hospitalizations. This study recommends revisiting mask mandates as new variants of COVID-19 spread and pressures return to the healthcare system.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This analysis evaluates the effectiveness of non-pharmaceutical interventions on COVID-19 transmission across states. Non-pharmaceutical interventions evaluated include the reopening of restaurants and bars, wearing facial masks in public, and lockdowns.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This analysis provides a framework for navigating the ethnical concerns around the lifting of public health and social measures for people who are vaccinated against COVID-19. It warns against the unintended consequences of vaccination certificates in creating more division within communities.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Systematic Review/Meta-Analysis
This analysis explores regional variation in COVID-19 death rates across America. It unpacks the “two Americas” narrative of some parts of the country having high demand for vaccines and others having widespread vaccine hesitancy, and shows that a divide between rates of exceeds death existed prior to the introduction in vaccines. This difference is likely due to a difference in mask use, social distancing, and other behaviors. Results underscore the importance of excess mortality measures such as wastewater testing to get a more accurate picture.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This article describes an approach to virtual recruitment to engage rural residents with atrial fibrillation in a clinical trial during the COVID-19 pandemic. The authors mainly report process outcomes related to successful recruitment and retention of trial participants, and qualitative data on participants experiences.